First in a new class of anti-emetics
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Medication Prior Authorization Biggest Daily Challenge for 1 in 5 Prescribers, Survey Says
Read More
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
Listen
FDA Approves Ajovy for Childhood Migraine Prevention
FDA Grants Accelerated Approval For Targeted Drug for Rare Brain Tumor
Valneva Updates Safety Label of Chikungunya Virus Vaccine
FDA Approves Presbyopia Treatment, VIZZ